Researchers found that a single instance of CRISPR/Cas9 gene editing can protect endothelial cells indefinitely from the degeneration that would otherwise cloud the cornea.
NOW SHOWING: Diagnosing and Treating All Stages of Neurotrophic Keratitis
Visit www.NKCaseTheater.com to view this online CME activity.
This continuing medical education activity is provided by MedEdicus LLC.
Public & Patients
Museum of the Eye